HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Top Medical News

How Many People Contract Omicron Without Knowing?

August 18th 2022

56% of adults with evidence of Omicron seropositivity did not know they were infected.

WHO Updates HCV Recommendations in Pursuit of 2030 Goals

August 18th 2022

WHO issues new HCV treatment recommendations that include "radical simplification" of care pathways, in pursuit of testing and treatment goals.

Risk Factors for “Long COVID” in Children

August 18th 2022

More symptoms, older age, and longer hospitalization time increased the risk of post-COVID-19 conditions (long COVID) in children.

Risk Factors for Primary and Recurrent C. difficile Infection (CDI)

August 17th 2022

Drs Lodise and Feuerstadt discuss risk factors for C. difficile infection (CDI).

C. difficile and C. difficile Infection (CDI) Overview and Risk Factors for CDI

August 17th 2022

A gastroenterologist, Dr. Paul Feuerstadt, provides an overview of C. difficile infection (CDI) and vegetative and spore phases of CDI.

Conference Coverage
View All >>

10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups

August 9th 2022

Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.

Biktarvy Effective for HIV Patients Coinfected With Hepatitis B

August 1st 2022

At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.

Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients

July 30th 2022

After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.

The Patient Impact of CDI, Preventing Reoccurrence

June 1st 2022

A clinician discusses the disease burden of reoccurring CDI, but sees a silver lining in the new investigational therapies potentially changing the treatment paradigm for the better.

Video Interviews
View All >>
10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups
In Low-Income Communities, Pharmacists Can Play a Critical Role in Vaccine Access
Infectious Disease Virologist: “Nobody Should be Scared of Paxlovid Rebound”
Trying to Reduce AMR Through Legislative Means
Utilizing Global Surveillance to Develop a Syphilis Vaccine
A Novel Device With COVID-19 Treatment Potential
Getting Men Screened and Being Proactive About Their Health
A Potential Monkeypox Therapy?
HPV Vaccination: A Prevention Measure Against Numerous Cancers
SNG001: Synairgen's COVID-19 Antiviral for the Immunocompromised
NACCHO: Addressing Public Health’s Vital Work
The Patient Impact of CDI, Preventing Reoccurrence
The Next Big Thing in Stewardship?
Rapid Diagnostic Testing’s Impact on Timing to Optimal Therapy
Measuring the Effectiveness of a Novel Antibiotic for Patients with Nontuberculous Mycobacterial Infections
Podcasts
View All >>
Episode 6: World Hepatitis Day: Where Do We Go From Here?
ACIP Preferentially Recommends Fluzone High-Dose Influenza Vaccine for Seniors
Episode 5: “A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People
Episode 4: Forging an Evolutionary Regulatory Path for Antibiotic Development
Episode 3: “We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs
Episode 2: Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Episode 1: Vaccine Inequity With Dr. Leonard Friedland
Vaccine Race: The Pfizer Vaccine with William Schaffner, MD
COVID-19 Vaccine Race: FDA Advisory Committee Meeting with Donald Alcendor, PhD
Vaccine Race: Mei Mei Hu on Developing, Researching a COVID-19 Vaccine